BioXcel Therapeutics, Inc. Skyrocketed
Mon, Aug 04, 2025 at 07:01 PM
BioXcel Therapeutics, Inc. (BTAI:NASDAQ) soared at $2.54, representing a gain of 85.4%. On Mon, Aug 04, 2025, BTAI:NASDAQ touched a New 2-Week High of $2.54. The stock got featured on our News Catalysts scanner on Fri, Aug 01, 2025 at 09:01 AM in the 'BIOTECH' category. From Mon, Jul 21, 2025, the stock recorded 40.00% Up Days and 18.18% Green Days
The stock spiked on Mon, Mar 03, 2025 at $6.83 with a volume of 146M+.
About BioXcel Therapeutics, Inc. (BTAI:NASDAQ)
BioXcel Therapeutics Inc is a clinical-stage biopharmaceutical company which is focused on drug development utilizing novel artificial intelligence (AI) to identify the next wave of medicines across neuroscience and immuno-oncology.
Top 10 Gainers:
- Ikena Oncology, Inc. (IKNA:NASDAQ), 1152.55%
- Verb Technology Company, Inc. (VERB:NASDAQ), 114.27%
- Psyence Biomedical Ltd. (PBM:NASDAQ), 92.37%
- CommScope Holding Company, Inc. (COMM:NASDAQ), 86.26%
- BioXcel Therapeutics, Inc. (BTAI:NASDAQ), 85.4%
- Steelcase Inc. (SCS:NYSE), 62.87%
- Earlyworks Co., Ltd (ELWS:NASDAQ), 52.56%
- CASI Pharmaceuticals, Inc. (CASI:NASDAQ), 51.16%
- Lichen International Limited (LICN:NASDAQ), 48.03%
- ATA Creativity Global (AACG:NASDAQ), 36.11%